Skip to main content
Back to News
Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou...
Funding
1 min read
US

Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou...

The AMW Read

Updates the Vertical AI - Healthcare/Bio segment with a player demonstrating the transition of AI agents from information retrieval to autonomous scientific discovery (agentic workflows) in drug discovery.
NoveltySignificance
Healthcare & Bio · Player MapAI Agents · Definition

Edison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomous researcher, Kosmos. 🧪 The system processes 1,500 papers and 42,000 lines of code per run, turning six months of labor into a 12-hour task. With a 79 percent reproducibility rate, it has already identified novel genetic targets for heart failure. This marks a structural pivot where AI agents transition from simple information retrieval to verifiable, high-speed scientific discovery. 🚀

#AI #Biotech #EdisonScientific #Innovation

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  2. 1mo agoMedipal launches Medipal AI agent platform for specialized clinic operationsMedipal
  3. 1mo agoAmbience Healthcare unveiled a multiyear AI platform roadmap that extends clinical intelligence acro...Ambience Healthcare
  4. 1mo agoSynthpop closed a $15M Series A (total funding $23M) to scale its multi‑agent AI platform that autom...Synthpop
  5. 5mo agoEdison Scientific raised 70 million dollars at a 250 million dollar valuation to scale its autonomou... · THIS ARTICLE

More news from Edison Scientific

Stay updated with the latest news and announcements from Edison Scientific.

View all Edison Scientific news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard